ACIONT, INC.

Address

350 WEST 800 NORTH, STE 320
SALT LAKE CITY, UT, 84103-

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Non-Invasive Treatment for Uveitis

    Amount: $2,029,592.00

    DESCRIPTION (provided by applicant): The aim of this innovative proposal is to commercialize a non-invasive topical product that treats uveitis which is safe and easy to administer. Uveitis is the thi ...

    SBIRPhase II2013Department of Health and Human Services
  2. Non-Invasive Drug Delivery to Treat Posterior Uveitis

    Amount: $133,202.00

    Intermediate and posterior uveitis cause 10% of blindness in the U.S. The mainstay of therapy is to eradicate the infectious cause and to quell the inflammation with corticosteroids or immunosuppressa ...

    SBIRPhase I2004Department of Health and Human Services
  3. NON-INVASIVE BLOOD PHENYLALANINE MONITOR

    Amount: $159,509.00

    DESCRIPTION (provided by applicant): Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH). Without PAH, the patient with PKU cannot metabolize phenylalanine (PHE) to tyros ...

    SBIRPhase I2002Department of Health and Human Services
  4. IMPROVED NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE

    Amount: $140,992.00

    The accurate measurement of blood glucose concentration is important in the management of diabetes. Current methods of glucose monitoring involve piercing the skin and collecting blood samples for ana ...

    SBIRPhase I2002Department of Health and Human Services
  5. Non-Invasive Drug Delivery to Treat Severe Uveitis

    Amount: $2,171,040.00

    DESCRIPTION (provided by applicant): The overarching aim of this innovative proposal is to develop and then commercialize a non-invasive topical product which is safe and easy to administer that treat ...

    SBIRPhase IIDepartment of Health and Human Services
  6. Novel Method for the Ocular Iontophoretic Delivery of Avastin and Lucentis

    Amount: $214,000.00

    DESCRIPTION (provided by applicant): Iontophoresis is a method of using a mild electrical current to enhance the penetration of a drug through tissue. Our long term goal is to develop the Visulex(r) o ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government